美敦力任命两名新董事并成立委员会 以提振股价

Core Viewpoint - Medtronic, a medical device manufacturer, is taking steps to boost its struggling stock price by adding two new independent directors to its board and forming a committee [1] Group 1 - The company announced the addition of John Groetelaars, a former interim CEO of Dentsply Sirona, and Bill Jellison, a former CFO of Stryker, as independent directors [1] - The formation of a new committee is part of the company's strategy to enhance governance and potentially improve investor confidence [1]